Edition:
United Kingdom

Strongbridge Biopharma plc (SBBP.OQ)

SBBP.OQ on NASDAQ Stock Exchange Global Select Market

2.94USD
24 May 2019
Change (% chg)

$0.01 (+0.34%)
Prev Close
$2.93
Open
$2.93
Day's High
$3.00
Day's Low
$2.89
Volume
20,093
Avg. Vol
41,697
52-wk High
$7.55
52-wk Low
$2.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 4.34 -0.340
FY 2018 Dec '18 4.51 1.690
Sep '18 5.35 -0.438
Jun '18 4.30 -0.058
Mar '18 3.87 -0.658
FY 2017 Dec '17 2.98 -0.471
Sep '17 2.53 -0.982
Jun '17 1.53 -0.854
Mar '17 0.00 -0.834
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 7 4.73 5.04 4.40 --
Quarter Ending Sep-19 7 5.02 5.56 4.45 --
Year Ending Dec-19 7 19.47 20.96 17.69 37.00
Year Ending Dec-20 5 31.11 48.34 23.17 69.07
Earnings (per share)
Quarter Ending Jun-19 5 -0.32 -0.25 -0.41 --
Quarter Ending Sep-19 5 -0.31 -0.25 -0.41 --
Year Ending Dec-19 4 -1.33 -1.24 -1.57 -1.48
Year Ending Dec-20 5 -0.90 -0.69 -1.01 -0.95
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 3.44 31.17 35.48
P/E High - Last 5 Yrs. 6.99 50.33 57.43
P/E Low - Last 5 Yrs. 6.99 27.08 28.10
Beta 0.60 0.96 0.95
Price to Sales (TTM) 8.61 7.53 9.28
Price to Book (MRQ) 1.64 3.58 4.15
Price to Tangible Book (MRQ) 2.62 3.87 4.94
Price to Cash Flow (TTM) 3.25 22.40 24.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.86 1.68
Dividend Yield - 5 Year Avg -- 1.41 1.30
Dividend 5 Year Growth Rate -- 6.56 6.71
Payout Ratio(TTM) 0.00 39.75 35.42

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 12.22 14.95 16.40
Sales (TTM) vs TTM 1 Yr. Ago 69.48 6.25 8.26
Sales - 5 Yr. Growth Rate -- 9.16 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.31 19.17 19.71
EPS (TTM) vs TTM 1 Yr. Ago 128.81 -- --
EPS - 5 Yr. Growth Rate -- 5.66 7.23
Capital Spending - 5 Yr. Growth Rate 176.97 7.28 8.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.96 2.42 2.43
Current Ratio (MRQ) 5.15 3.38 3.36
LT Debt to Equity (MRQ) 0.00 13.50 14.37
Total Debt to Equity (MRQ) 0.00 18.38 19.78
Interest Coverage (TTM) -1.80 7.80 13.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 77.66 51.81 50.23
Gross Margin - 5 Yr. Avg. -- 50.55 51.31
EBITD Margin (TTM) -409.06 -- --
EBITD - 5 Yr. Avg -840.87 17.44 15.84
Operating Margin (TTM) 147.36 0.98 -4.60
Operating Margin - 5 Yr. Avg. -613.96 13.61 11.09
Pre-Tax Margin (TTM) 234.35 0.54 -4.95
Pre-Tax Margin - 5 Yr. Avg. -737.51 19.46 15.89
Net Profit Margin (TTM) 227.79 -3.11 -8.72
Net Profit Margin - 5 Yr. Avg. -732.48 14.63 11.14
Effective Tax Rate (TTM) 2.80 19.56 19.94
Effective Tax Rate - 5 Yr. Avg. -- 22.54 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 174,528 883,631,482 746,541,307
Net Income/Employee (TTM) 397,557 103,176,553 87,192,468
Receivable Turnover (TTM) 6.24 5.39 5.67
Inventory Turnover (TTM) 1.41 2.51 3.66
Asset Turnover (TTM) 0.12 0.82 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 26.59 9.71 9.44
Return on Assets - 5 Yr. Avg. -40.02 10.97 10.47
Return on Investment (TTM) 29.71 12.05 11.75
Return on Investment - 5 Yr. Avg. -44.50 13.96 13.33
Return on Equity (TTM) 85.27 13.36 16.52
Return on Equity - 5 Yr. Avg. -79.91 15.26 14.90
  1 Year 3 Year 5 Year
Sales % 155.85 -- --
EPS (TTM) % 120.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Strongbridge Biopharma plc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -40.12 -37.71 5 22
13 Week -38.11 -38.84 16 20
26 Week -43.57 -47.43 23 11
52 Week -59.73 -61.13 25 63
YTD -34.38 -41.79 18 17
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.43%
# of Holders: 67
Total Shares Held: 35,986,130
3 Mo. Net Change: -354,091
# New Positions: 17
# Closed Positions: 7
# Increased Positions: 37
# Reduced Positions: 20
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.